Live Breaking News & Updates on Hudson Chief Executive Officer

Stay updated with breaking news from Hudson chief executive officer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Collaboration to deliver inflammatory bowel disease treatment

Sanofi (EURONEXT: SAN and NASDAQ: SNY) and Teva Pharmaceuticals, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announce today a collaboration to co-develop and co-commercialize asset TEV’574, currently in Phase 2b clinical trials for the treatment of Ulcerative Colitis and Crohn's Disease, two types of inflammatory bowel disease. ....

United States , Richard Francis , Paul Hudson , Teva Pharmaceutical Industries Ltd , Teva Pharmaceuticals , From Sanofioct , Teva Pharmaceutical Industries , Ulcerative Colitis , Hudson Chief Executive Officer , North America , Francis President , Chief Executive Officer ,